Quantum BioPharma Ltd.
QNTM
$30.18
$4.4517.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.58M | -5.36M | -3.83M | -3.11M | -1.90M |
| Total Depreciation and Amortization | 129.70K | 112.80K | 120.80K | 136.80K | 120.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.90M | -2.96M | -372.70K | 44.00K | 366.10K |
| Change in Net Operating Assets | 284.20K | 7.37M | 618.20K | 2.32M | -556.30K |
| Cash from Operations | -4.26M | -835.80K | -3.46M | -606.50K | -1.97M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.35M | 1.24M | -3.46M | 738.20K | -22.10K |
| Cash from Investing | -1.35M | 1.24M | -3.46M | 738.20K | -22.10K |
| Total Debt Issued | 3.11M | 1.01M | -302.80K | 15.90K | 286.90K |
| Total Debt Repaid | -23.30K | -29.80K | -4.60K | -14.60K | -14.70K |
| Issuance of Common Stock | 45.90K | 1.49M | 7.05M | 1.84M | 296.40K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.13M | 2.47M | 6.74M | 1.84M | 568.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.48M | 2.88M | -186.40K | 1.98M | -1.43M |